- IsoRay Takes Liberties With Lung Cancer Study Results to Prop Up Stock Price
- Carnival CEO Aims to Bust the Biggest Myths About the Cruise Industry
- Boomers' Biggest Retirement Regret? They Didn't Work Longer
- Shadow Work: How Businesses Are Turning Us All Into Unpaid Laborers
- America's 10 Favorite Fast-Food Burgers
Doctor asks when profit becomes profiteering after Retrophin raises drug price by 20 times.
An inside look at how Intuitive Surgical botched the upgrade cycle for its high-price surgical robots.
A doctor rants against the naysyers and nitpickers slamming robotic surgery. It's here for good, so get used to it.